The i-α1-ECD was found to bind more efficiently anti-nAChR monoclonal antibodies (mAbs), as well as autoantibodies from MG patients compared to the homologous protein previously expressed in P. pastoris (y-α1-ECD). Here, CHRNA4 is linked to myasthenia gravis.